Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Laboratory analyzers are standalone instruments used to measure electrolytes from serum. Benchtop analyzers use individual biosensor technology. The operational cost for benchtop analyzers is lower compared to portable analyzers.

EME blood gas and electrolyte analyzers market is estimated to account for US$ 139.4 Mn in terms of value in 2020 and is expected to reach US$ 195.7 Mn in terms of value by the end of 2027.

EME Blood Gas and Electrolyte Analyzers Market: Drivers

Increasing prevalence of chronic disorders is expected to propel growth of EME blood gas and electrolyte analyzers market over the forecast period. For instance, according to the World Health Organization, Saudi Arabia recorded 24,485 new cases of cancer and 10,518 deaths due to the disease in 2018.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the World Health Organization, The geriatric population in Europe is expected to increase from 894 million in 2019 to 910 million in 2020. The number of people aged 85 years and older is projected to rise from 14 million to 19 million by 2020 and to 40 million by 2050.

Laboratory analyzers held dominant position in EME blood gas and electrolyte analyzers market in 2019, accounting for 38.1% share in terms of value, followed by benchtop analyzers and portable analyzers, respectively.

Figure 1. EME Blood Gas and Electrolyte Analyzers Market Share (%), by Value, by Modality, 2019

EME Blood Gas and Electrolyte Analyzers  | Coherent Market Insights

EME Blood Gas and Electrolyte Analyzers Market: Restraints

Lack of trained personnel in remote areas to operate blood gas and electrolyte analyzers is a factor hampering growth of the market.

Moreover, complex functioning and understanding of data for these analyzers is also expected to limit the market growth.

request-sample

EME Blood Gas and Electrolyte Analyzers Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 133.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.0% 2027 Value Projection: US$ 195.7 Mn
Geographies covered:
  • Europe: Germany, U.K., Spain, France, Italy, Nordics, Denmark, Finland, Iceland, Norway, Sweden, Rest of Europe
  • Middle East: Saudi Arabia, UAE, Turkey, GCC Countries, Israel, Rest of Middle East
Segments covered:
  • By Product: Blood Gas Analyzers, Electrolyte Analyzers, Combination Analyzers, Consumables.
  • By Modality: Laboratory Analyzers, Benchtop Analyzers, Portable Analyzers.
  • By End User: Hospitals, Diagnostic Centres, Ambulatory Surgical Centres, Clinics.
Companies covered:

Abbott Laboratories, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, and Instrumentation Laboratories (Werfen)

Growth Drivers:
  • High prevalence of uveitis
  • Number of treatment options
Restraints & Challenges:
  • Limited studies on efficacy comparison of treating agents
  • Challenging manufacturing process

EME Blood Gas and Electrolyte Analyzers Market: Opportunities

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in EME blood gas and electrolyte analyzers market. For instance, in the U.K, from Jan 31 to 4:44pm CEST, 24 June 2020, there have been 306,214 confirmed cases of COVID-19 with 42,927 deaths, as reported to the World Health Organization.   

Moreover, upgrading of devices is also expected to aid in growth of the market. For instance, in September 2019, Radiometer Ltd. demonstrated its range of point of care solutions at the Institute of Biomedical Science (IBMS) Congress 2019, held in the U.K., with new features such as ABL90 FLEX PLUS blood gas analyzer with creatinine and urea and AQT90 FLEX immunoassay analyzer including sepsis biomarkers.

EME blood gas and electrolyte analyzers market was valued at US$ 133.2 Mn in 2019 and is forecast to reach a value of US$ 195.7 Mn by 2027 at a CAGR of 5.0% between 2020 and 2027.

Figure 2. EME Blood Gas and Electrolyte Analyzers Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

EME Blood Gas and Electrolyte Analyzers  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2020, Nova Biomedical secured clearance from the U.S. Food and Drug Administration for its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care (POC) use.

Blood gas and electrolyte analyzers are vulnerable to cyber-attacks that enable attackers to compromise the confidentiality, integrity, and availability of the devices. For instance, in June 2018, Siemens Healthineers warned about two cybersecurity vulnerabilities affecting its RAPID blood-gas analyzers.

Regulations

EU 5

  • The upcoming In-Vitro Diagnostic (IVD) Device Regulation is suggestively different to the current IVD Directive, comprising changed classification rules and necessities for conformity assessment. The proposed Regulation introduces a new risk-rule classification system based on the Global Harmonization Task Force (GHTF) classification rules.
  • This alteration to the classification system will have an effect on all manufacturers of IVDs. The majority of IVDs are currently self-certified, but once the Regulation comes into effect, most will need the services of acquainted body to classify their devices.
  • In the new classification system, IVD devices will be divided into four Classes of risk: A (lowest risk), B, C and D (highest risk). By using the seven classification rules, devices will be divided into one of the four classes that will dictate notified body involvement
  • The new Regulation will become applicable five years after its entry into force, to take into account the significant changes to the classification system for IVDs and to the conformity assessment procedures.

EME Blood Gas and Electrolyte Analyzers Market: Competitive Landscape

Major players operating in EME blood gas and electrolyte analyzers market include, Abbott Laboratories, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, and Instrumentation Laboratories (Werfen).

EME Blood Gas and Electrolyte Analyzers Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2020, Nova Biomedical launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries.

Major players in the market are also focused on adopting partnership strategies to enhance their market share. For instance, in April 2020, Accelerate Diagnostics, Inc. partnered with BioCheck, Inc. for the distribution of the BioCheck MS-FAST, a fully-automated chemiluminescence immunoassay analyzer, along with BioCheck's SARS-CoV-2 tests for the detection of IgG and IgM antibodies, in North America, Europe and the Middle East.

Blood gas analysis is performed for critically ill patient suffering from a respiratory or metabolic disorder. In blood gas analysis includes measurement of the amount of oxygen, carbon dioxide, and the acidity of pH in the blood as well as concentrations of other parameters such ascreatinine, electrolytes, glucose, hemoglobin, and lactate. Blood gas analyzers use electrodes to determine pH, partial pressure of carbon dioxide, and amount of oxygen in the blood. Imbalances in oxygen, carbon dioxide, and pH levels in blood can indicate the presence of certain medical conditions such as heart failure, hemorrhage, kidney failure, chemical poisoning, uncontrolled diabetes, or drug overdose.

Restraints of the EME Blood Gas and Electrolyte Analyzers Market

Major factors hampering the growth of the uveitis treatment market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.

Key features of the study:

  • This report provides in-depth analysis of the EME blood gas and electrolyte analyzers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the EME blood gas and electrolyte analyzers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, and Instrumentation Laboratories (Werfen).
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The EME blood gas and electrolyte analyzers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • EME Blood Gas and Electrolyte Analyzers Market, By Product:
    • Blood Gas Analyzers
    • Electrolyte Analyzers
    • Combination Analyzers
    • Consumables
  • EME Blood Gas and Electrolyte Analyzers Market, By Modality:
    • Laboratory Analyzers
    • Benchtop Analyzers
    • Portable Analyzers
  • EME Blood Gas and Electrolyte Analyzers Market, By End User:
    • Hospitals
    • Diagnostic Centres
    • Ambulatory Surgical Centres
    • Clinics
  • EME Blood Gas and Electrolyte Analyzers Market, By Geography:
    • Europe
      • By Product
        • Blood Gas Analyzers
        • Electrolyte Analyzers
        • Combination Analyzers
        • Consumables
      • By Modality
        • Laboratory Analyzers
        • Benchtop Analyzers
        • Portable Analyzers
      • By End User
        • Hospitals
        • Diagnostic Centres
        • Ambulatory Surgical Centres
        • Clinics
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Nordics
        • Denmark
        • Finland
        • Iceland
        • Norway
        • Sweden
        • Rest of Europe
    • Middle East:
      • By Product
        • Blood Gas Analyzers
        • Electrolyte Analyzers
        • Combination Analyzers
        • Consumables
      • By Modality
        • Laboratory Analyzers
        • Benchtop Analyzers
        • Portable Analyzers
      • By End User
        • Hospitals
        • Diagnostic Centres
        • Ambulatory Surgical Centres
        • Clinics
      • By Country:
        • Saudi Arabia
        • UAE
        • Turkey
        • GCC Countries
        • Israel
        • Rest of Middle East
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Medica Corporation
    • Nova Biomedical
    • Radiometer Medical ApS
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthcare
    • EKF Diagnostics
    • ERBA Diagnostics Mannheim GmbH
    • Instrumentation Laboratories (Werfen)

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Modality
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. EME Blood Gas and Electrolyte Analyzers Market, By Product, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Blood Gas Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Electrolyte Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Combination Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. EME Blood Gas and Electrolyte Analyzers Market, By Modality, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Laboratory Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Benchtop Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Portable Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. EME Blood Gas and Electrolyte Analyzers Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Centres
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centres
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. EME Blood Gas and Electrolyte Analyzers Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Nordics
        • Denmark
        • Finland
        • Iceland
        • Norway
        • Sweden
        • Rest of Europe
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Saudi Arabia
        • UAE
        • Turkey
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medica Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Nova Biomedical
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Radiometer Medical ApS
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Siemens Healthcare
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • EKF Diagnostics
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ERBA Diagnostics Mannheim GmbH
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Instrumentation Laboratories (Werfen)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 26 figures on “Blood Gas and Electrolyte Analyzers Market – UAE forecast to 2027.

Frequently Asked Questions

EME blood gas and electrolyte analyzers market was valued at US$ 133.2 Mn in 2019 and is forecast to reach a value of by 2027 at a CAGR of 5.0% between 2020 and 2027.
Major factor driving the growth of EME blood gas and electrolyte analyzers market during the forecast period include increasing prevalence of chronic disorders, and product launches.
Major factors hampering the growth of the blood gas and electrolyte analyzers market during the forecast period constitutes of lack of trained personnel, and complex functioning and understanding of data for these analyzers.
Laboratory analyzers held dominant position in the EME Blood Gas and Electrolyte Analyzers market in 2019.
Germany blood gas and electrolyte analyzers market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Abbott Laboratories, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, and Instrumentation Laboratories (Werfen).
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner